Clinical Trials in Detroit

Showing 15601-15620 of 19,719 trials

Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277®

NCT01898286

This is an extension study to evaluate the safety and tolerability of long-term treatment with DiaPep277® and to determine the long-term treatment effect of DiaPep277® on parameters of metabolic control and on preservation of beta-cell function in subjects who have long exposure to DiaPep277®.

Type 1 Diabetes

Andromeda Biotech Ltd.38 participantsStarted Oct 2013

Atlanta, Georgia, United States • Detroit, Michigan, United States • Asheville, North Carolina, United States

COMPLETEDPhase 1< 1 mile

A Study of Vismodegib in Patients With Advanced Solid Malignancies Including Hepatocellular Carcinoma With Varying Degrees of Renal or Hepatic Function

NCT01546519

This is a Phase Ib, open-label, multiple-center, multiple-dose study designed to evaluate the pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies (including hepatocellular carcinoma and lymphoma) that are refractory to standard therapy or for whom no standard therapy exists.

Cancer

Genentech, Inc.31 participantsStarted Mar 2012

Chicago, Illinois, United States • Baltimore, Maryland, United States • Detroit, Michigan, United States +2 more locations

COMPLETEDPhase 2< 1 mile

S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma

NCT00003590

RATIONALE: Drugs used in chemotherapy such as hydroxyurea use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well hydroxyurea works in treating patients with unresectable benign meningioma.

Adult Meningioma

SWOG Cancer Research Network29 participantsStarted Nov 1998

Fairbanks, Alaska, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +130 more locations

Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277®

A Study of Vismodegib in Patients With Advanced Solid Malignancies Including Hepatocellular Carcinoma With Varying Degrees of Renal or Hepatic Function

S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma

Find Trials by Condition in Detroit

Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis

Effectiveness of Video Messaging About Diet, Exercise and Weight Gain in Pregnancy in Regional and National Samples

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients

A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)

Vistakon Investigational Contact Lenses Worn for Daily Wear

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor

Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology

Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes Mellitus

An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder

Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes

A Study to Identify and Characterize LAL-D Patients in High-risk Populations

RSV F Dose-Ranging Study in Women

A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13